Table 2 Baseline data of participating practices
| Â | A | B | C | D | Total |
|---|---|---|---|---|---|
Volume of registered patients | 2 * norm1 | 1.5* norm | 2* norm | >  2 * norm |  |
Socioeconomic status | Deprived | Mixed (deprived/advantageous) | Advantageous | Deprived | Â |
Primary intervention | SMS service | Exploration of patient needs | Patient ePortal | Consultation reduction |  |
Participants (n) | 49 | 31 | 11 | 35 | 126 |
Age (years): median [IQR] | 68 [61–72] | 68 [64–76] | 70 [59–80] | 64 [62–70] | 68 [62–72] |
Diabetes duration (years): median [IQR] | 7 [3–9] | 6 [2–8] | 3 [2–8] | 7 [3–10] | 6 [3–9] |
Gender: female n (%) | 21 (43%) | 17 (55%) | 3 (27%) | 14 (40%) | 55 (44%) |
Monitoring as recommended, n (%) | 48 (98%) | 25 (81%) | 11 (100%) | 31 (89%) | 115 (91%) |
DTSQ Status2: mean (SD) | 30.8 (6.5) | 32.3 (3.9) | 31.3 (6.0) | 29.6 (5.4) | 30.9 (5.6) |
WHO-5: mean (SD) | 54.7 (25.0) | 68.2 (15.5) | 66.5 (26.4) | 53.9 (22.9) | 58.4 (23.3) |
EQ-VAS: mean (SD) | 65.3 (22.2) | 77.8 (16.6) | 82.8 (11.1) | 65.8 (16.5) | 69.5 (17.7) |